Aviva’s Aurora Cannabis ACB Stock Holding History

Aviva’s Portfolio ACB Stock Details ACB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-2,266	Closed	-$2.45M	–	794
2019 Q1	$2.45M	Sell	2,266 -43	-2%	-$38.5K	0.02%	617
2018 Q4	$1.38M	Buy	+2,309	New	+$1.7M	0.01%	680

Other funds holding ACB

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EMG

ETF Managers Group Summit, New Jersey $3.1B AUM 17.12% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

TD Asset Management Toronto, Ontario, Canada $123B AUM 34.51% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

Public Sector Pension Investment Board (PSP Investments) Montreal, Quebec, Canada $32.1B AUM 31.84% 1-Year Est. Return

Swiss National Bank Zurich, Switzerland $174B AUM 30.96% 1-Year Est. Return

Aviva's ACB Position: Q2 2019 in Review

Aviva sold out of Aurora Cannabis (ACB) in Q2 2019, closing a stake of 2,266 shares — an estimated $2.45M sold.

Aviva first reported a position in ACB in Q4 2018 and held it in 2 quarters. The position peaked at $2.45M in Q1 2019. 347 funds tracked by Wall St. Rank hold ACB as of Q2 2019.

Aviva reported no remaining Aurora Cannabis position as of Q2 2019 after selling out during the quarter.
Aviva sold 2,266 Aurora Cannabis shares in Q2 2019, an estimated $2.45M.
Aviva first reported a position in Aurora Cannabis in Q4 2018 and held it in 2 quarters.
Aviva's Aurora Cannabis position peaked at $2.45M in Q1 2019.
347 funds tracked by Wall St. Rank held Aurora Cannabis as of Q2 2019.

Based on Aviva's 13F filing for Q2 2019, filed 30 Jul 2019.